Therefore, the aim of our study was to integrate these different data types to evaluate to what extent PON1 status is associated with NAFLD presence and severity and with the associated metabolic dysregulation. The gene discussed is PON1; the disease is metabolic dysfunction-associated steatotic liver disease.